Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05094089 · ClinicalTrials.gov registry record
Assessment of GORE® SYNECOR Biomaterial in Focused Patient Populations and Long-Term Application
A clinical trial of Hernia, Ventral and Hernia Incisional Ventral, sponsored by W.L.Gore & Associates.
- Active
- Registry status
- 320
- Enrollment target
- 15
- Study locations
NCT05094089 is a study of Hernia, Ventral and Hernia Incisional Ventral that is active but no longer recruiting, run by W.L.Gore & Associates. The registered enrollment target is 320 participants, above the 138-participant average among 7 other Hernia, Ventral trials with a reported enrollment target (132% higher). The trial reports 15 study locations across 9 states.
The verdict
NCT05094089, a study of Hernia, Ventral and Hernia Incisional Ventral, is active but no longer recruiting, sponsored by W.L.Gore & Associates.
- ACTIVE NOT RECRUITING
- Registry status
- 320 participants
- Enrollment target
- 15
- Study locations
Study Summary
The SYN 20-01 Study is a non-interventional, prospective, multicenter, multicohort, international, post-market clinical investigation looking into the assessment of GORE® SYNECOR Biomaterial in focused patient populations and in long-term application. Patients with ventral / incisional hernia amenable to hernia mesh repair will be enrolled into two cohorts (US and EU cohort) and followed-up over the period of 60 months.
Conditions Studied
Interventions
- DEVICE Hernia repair with mesh
Study Locations (15)
Other
- Ospedale Civile di Baggiovara - Baggiovara
- Vincenzo Monaldi Hospital - Naples
- Sapienza Università di Roma - Roma
- University Hospital Virgen Macarena - Department of General And Digestive Surgery - Seville
- Hospital Quirón Salud-Sagrado Corazón - Seville
- University Hospitals Birmingham NHS Foundation Trust - Queen Elizabeth Hospital Birmingham - Birmingham
- Walsall Manor Hospital - Walsall
Georgia
- Emory Saint Joseph's Hospital - Atlanta
Massachusetts
- Tufts Medical Center - Boston
Michigan
- Corewell Health - Grand Rapids
New Mexico
- Lovelace Women's Hospital - Albuquerque
New York
- Stony Brook University Hospital - Stony Brook
North Carolina
- Novant Health New Hanover Regional Medical Center - Wilmington
South Carolina
- Prisma Health Greenville Memorial Hospital - Greenville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 320 participants |
| Start Date | 2023-02-24 |
| Est. Completion | 2030-07-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05094089
The ClinicalTrials.gov registry entry for NCT05094089 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 320 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 138-participant average among 7 other Hernia, Ventral trials with a reported enrollment target (132% higher). The listed sponsor is W.L.Gore & Associates, which has 53 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Hernia, Ventral appearing as the primary indexed condition, and to 1 intervention - of which Hernia repair with mesh is the first listed.
NCT05094089 reports 15 study locations spanning 9 distinct geographic areas - top geographies include Other, Georgia, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05094089 about?
NCT05094089 is a clinical study titled "Assessment of GORE® SYNECOR Biomaterial in Focused Patient Populations and Long-Term Application". The SYN 20-01 Study is a non-interventional, prospective, multicenter, multicohort, international, post-market clinical investigation looking into the assessment of GORE® SYNECOR Biomaterial in focused patient populations and in long-term application. Patients with ventral / incisional hernia amena...
What is the current status of trial NCT05094089?
This trial is currently active not recruiting. The enrollment target is 320 participants. The study started on 2023-02-24. Estimated completion is 2030-07-31.
What conditions does trial NCT05094089 study?
This clinical trial studies the following conditions: Hernia, Ventral, Hernia Incisional Ventral, Hernia Incisional.
What interventions are being tested in trial NCT05094089?
The interventions under investigation include: Hernia repair with mesh (DEVICE).
Who is sponsoring clinical trial NCT05094089?
This trial is sponsored by W.L.Gore & Associates, which has 53 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05094089 being conducted?
This trial has 15 study locations across Georgia, Massachusetts, Michigan, New Mexico, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hernia, Ventral
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
GORE® ENFORM Biomaterial Product Study
RECRUITING · NA
-
Ventral or Inguinal Hernia, Robotically Repaired With OviTex Mesh
RECRUITING · NA
-
A Study to Understand the Utility of the Force Feedback Instruments in Robotic Procedures Using da Vinci 5 Robot
RECRUITING
-
Transorb™ Self-Gripping Resorbable Mesh in High-risk Subjects Undergoing Open Repair of Ventral Hernia
ACTIVE NOT RECRUITING · NA
-
Abdominal Wall Tension in Patients Undergoing Ventral Hernia Repair Without Component Separation
ACTIVE NOT RECRUITING
-
RCT of Two Noncrosslinked Porcine Acellular Dermal Matrices in Ab Wall Reconstruction
COMPLETED · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.